Intellance-2: omics data on recurrent glioblastoma patients participating in the Intellance-2 clinical trial, prior to treatment.
|Study ID||Alternative Stable ID||Type|
This study contains omics data from patients from the Intellance-2 clinical trial, in which effectiveness of ABT414 in EGFR amplified recurrent glioblastoma patients was tested. Patients were randomly assigned to one of three arms: (1) standard of care treatement (TMZ or CCNU), (2) Only ABT414 and (3) ABT414 + (TMZ|CCNU)
Study Datasets 3 datasets.
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
Intellance-2: rRNA-minus RNA-seq
|Illumina NovaSeq 6000||224|
Intellance-2: TruSight Tumor 170 panel based RNA-seq
Intellance-2: TruSight Tumor 170 panel based DNA-seq
Who archives the data?